Tiziana Life Sciences CEO Ivor Elrifi files initial beneficial ownership statement
TLSA•CEO reports share and RSU holdings
- Tiziana Life Sciences CEO Ivor Elrifi reported 3,805,261 common shares, with 3,150,000 restricted stock units exercisable Aug. 15, 2026 at $1.26.
